{
  "docId": "019dd923-5ca1-7489-b636-bc879d1b6d64",
  "docSlug": "17680cec2cbd3510",
  "documentTitle": "Accelerated Access Review UK Mapping",
  "authorId": "Deloitte",
  "authorName": "Deloitte",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.333,
  "pageNumber": 9,
  "pageCount": 109,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "pain_points",
  "function": "diagnose",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "CDx = co-diagnostics; Source: Stakeholder interviews, workshops and Deloitte analysis",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "process_diagram",
    "icon_grid"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b636-bc879d1b6d64/9",
  "deckHref": "/decks/019dd923-5ca1-7489-b636-bc879d1b6d64",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b636-bc879d1b6d64.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b636-bc879d1b6d64#slide-9",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Our research also highlighted a number of challenges that are specific to in vitro diagnostics by pathway stage.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-ba8c-7422-853a-5857a2ad9137",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.92,
        "x": 0.04,
        "y": 0.22
      },
      "kind": "diagram",
      "text": "Cross-cutting challenges and pathway stages",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "694e0ecd-e8ec-42e2-90e9-4e4da5f9660f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.2,
        "x": 0.73,
        "y": 0.48
      },
      "kind": "list",
      "text": "Local Commissioning and Adoption: Unclear route to market, Process duplication, Budget silos, Contracting",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "53c726b2-ece0-4df5-934a-6c4377abe555",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.2,
        "x": 0.27,
        "y": 0.48
      },
      "kind": "list",
      "text": "Regulation: Lack of early dialogue, Uneven requirements vs. in-house tests, Potential for greater regulatory burden",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58ffbc3d-8518-4d18-9ef2-1803c8d4784a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.88,
        "x": 0.06,
        "y": 0.25
      },
      "kind": "list",
      "text": "Alignment across key stakeholders, Counterproductive incentives, Data, evidence & measurement, Culture",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "853ea95c-b417-4a22-91f7-4860b8238fc7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.2,
        "x": 0.04,
        "y": 0.48
      },
      "kind": "list",
      "text": "Development: Lack of clinical & commercial capability, NHS trial approvals process, Lack of patent protection",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f1667c86-468b-4c93-a859-8b9f36cd97ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.2,
        "x": 0.5,
        "y": 0.48
      },
      "kind": "list",
      "text": "National Reimbursement: Lack of funding mandate, Lack of commercialisation capability, System requires Industry push, Usual funding streams don't cover CDx",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fb89ea1c-de39-49fe-a455-6c50b088849a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.85,
        "x": 0.04,
        "y": 0.11
      },
      "kind": "paragraph",
      "text": "Our research also highlighted a number of challenges that are specific to in vitro diagnostics by pathway stage",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e33186ab-8396-497e-ac49-0b4fa4c7500a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.04,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Notes: (1) CDx = co-diagnostics; Source: Stakeholder interviews, workshops and Deloitte analysis",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "38d82e94-6090-4e5d-b47b-ece4c6152a57",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.04,
        "y": 0.04
      },
      "kind": "title",
      "text": "Challenges: In vitro diagnostics",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "00806799-21d1-42cc-837a-4d02d9a66127",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "d8693005-b64c-4f99-b236-990d670f9006",
      "evidence": "This slide presents a list of specific challenges for in vitro diagnostics.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "0fa2950b-4b9f-4dc0-a842-74e87bc9c696",
      "evidence": "The slide uses a horizontal arrow-based process flow to map challenges to stages.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 9,
      "from": 5,
      "beatId": "0a043aaa-9d86-481c-b01c-e99e57aaaa1e",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem (Identify pain)",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "The document identifies key challenges in pharmaceuticals, medical devices, and in vitro diagnostics.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "216c31e8-2aee-4a6b-81ea-25d4d04ac422",
      "evidence": "The document highlights the consequences of not addressing the challenges, such as limited access to new treatments and technologies.",
      "position": 0,
      "objective": "What are the consequences of not improving access to medical innovations?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}